Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

Market Intel: Liquid Biopsy II – Emerging Companies Look For Liquid Gold

Aug 15 2018

• By Marion Webb

Related Content

Angle's Maiden M&A Fills Gaps In Liquid Biopsy Solution

Oct 05 2017

Market Intel: Can New Wave Of Tests Finally Nail Early Diagnosis Of Lung Cancer?

Jan 02 2017

Market Intel: Liquid Biopsy I – Analyzing Market Landmarks And Landmines

Aug 10 2018

Inivata Launches Search For New CEO

May 10 2018

ANGLE Reels In First Patient For Major US FDA Clinical Study

Apr 05 2018

Bio-Techne Makes Big Push Into Liquid Biopsy With Exosome Acquisition

Jun 27 2018

CLINICAL CORNER: Spectranetics’ DCB, Pixium’s Bionic Vision, Endologix EVAS, Biocartis’ Liquid Biopsy

Jun 03 2016

Related Companies

Exact Sciences Corp.

Biocartis NV

Johnson & Johnson

Epic Sciences, Inc.

Provista Diagnostics Inc.

Biocept, Inc.

Thermo Fisher Scientific

Amgen, Inc.

Merck KGaA

Freenome Inc.

Verily

Qiagen NV

23andMe, Inc.

Bristol Myers Squibb Company

Merck & Co., Inc.

Pfizer Inc.

Foundation Medicine, Inc.

ANGLE plc

Abbott

Inivata Ltd.

Bio-Techne Corporation

AstraZeneca PLC

GRAIL Inc.

Guardant Health, Inc.

Additional Topics

Personalized Medicine Commercial Market Intelligence Cancer Medical Device

More from Oncology

More from Device Area

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window